BOSE PUBLIC AFFAIRS GROUP

Lobbying for ASSOCIATION FOR PRESCRIPTION PSYCHEDELICS · Industry association representing pharmaceutical companies

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New York · House · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

FDA approval and regulation of prescription psychedelic therapies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.